<p>Mice that received BCG were immunized at week 0 and the H4-IC31® and BCG/H4-IC31® groups were subsequently immunized with H4 in IC31® at 19 and 22 weeks after initiating the experiment (A). The amount of IFNγ produced by splenocytes and PBMCs (pooled from five mice per group) in response to Ag85B and TB10.4 stimulation was evaluated by ELISA. The responses were evaluated two weeks after the first H4-IC31® immunization (B), and memory responses were evaluated six weeks after the second immunization in PBMCs pooled from n = 15 mice per group (C). Bars represent means and standard deviations of triplicate 72 hour culture-supernatants. Stimulation with media alone as well as ESAT-6 as a negative control antigen resulted in IFNγ secretion bel...
<p>Balb/c mice received BCG±CT <i>i.n.</i> followed by 1×10<sup>6</sup> CFU MVA85A 10 weeks later. L...
<p>Thirty days after vaccination, lung and spleen suspensions were stimulated <i>ex</i><i>vivo</i> w...
<p><b>A</b>, Immunization schedule to evaluate the immunogenicity of the SIVgag-LC3b fusion antigen....
<p>Mice were immunized as depicted in <a href="http://www.plosone.org/article/info:doi/10.1371/journ...
<p>Mice were primed i.d. with BCG and boosted i.d. at 11 and 17 weeks after the prime with successiv...
<p>Infant and adult mice were immunized s.c. with BCG, and the AdHu5Ag85A booster vaccine was admini...
<p>Six weeks after infection the level of protection was assessed in the lungs (upper panel) and spl...
<p>(A–B) BALB/c mice were vaccinated with 1×10<sup>6</sup> CFU of BCG Copenhagen by intranasal (i.n....
<p>Mice were primed with BCG[pWB206] or BCG[pHS207] (intraperitoneal vaccination; doses of 10<sup>7<...
<p>Groups of mice were primed with BCG-Gag (10<sup>7</sup> cfu) and BCG-Control (10<sup>7</sup> cfu)...
<p>Timeline is shown in (<b>a</b>). BALB/c mice were immunized <i>id</i> with 1×10<sup>4</sup> CFU B...
<p>Mice were either non-immunized (•) or immunized with BCG (○) two months before challenge. All mic...
<p>Groups of mice (n = 6/group) were primed i.d. with Ad5, MVA or Ad5+M expressing Ag85A and receive...
<p>(A–C) The lung and spleen cells of i.n. and s.c. BCG-vaccinated mice (<i>n</i> = 4/time point/gro...
<p>6 week old BALB/c mice were immunized with 10<sup>7</sup> viable BCG-SSI. Splenocytes recovered 3...
<p>Balb/c mice received BCG±CT <i>i.n.</i> followed by 1×10<sup>6</sup> CFU MVA85A 10 weeks later. L...
<p>Thirty days after vaccination, lung and spleen suspensions were stimulated <i>ex</i><i>vivo</i> w...
<p><b>A</b>, Immunization schedule to evaluate the immunogenicity of the SIVgag-LC3b fusion antigen....
<p>Mice were immunized as depicted in <a href="http://www.plosone.org/article/info:doi/10.1371/journ...
<p>Mice were primed i.d. with BCG and boosted i.d. at 11 and 17 weeks after the prime with successiv...
<p>Infant and adult mice were immunized s.c. with BCG, and the AdHu5Ag85A booster vaccine was admini...
<p>Six weeks after infection the level of protection was assessed in the lungs (upper panel) and spl...
<p>(A–B) BALB/c mice were vaccinated with 1×10<sup>6</sup> CFU of BCG Copenhagen by intranasal (i.n....
<p>Mice were primed with BCG[pWB206] or BCG[pHS207] (intraperitoneal vaccination; doses of 10<sup>7<...
<p>Groups of mice were primed with BCG-Gag (10<sup>7</sup> cfu) and BCG-Control (10<sup>7</sup> cfu)...
<p>Timeline is shown in (<b>a</b>). BALB/c mice were immunized <i>id</i> with 1×10<sup>4</sup> CFU B...
<p>Mice were either non-immunized (•) or immunized with BCG (○) two months before challenge. All mic...
<p>Groups of mice (n = 6/group) were primed i.d. with Ad5, MVA or Ad5+M expressing Ag85A and receive...
<p>(A–C) The lung and spleen cells of i.n. and s.c. BCG-vaccinated mice (<i>n</i> = 4/time point/gro...
<p>6 week old BALB/c mice were immunized with 10<sup>7</sup> viable BCG-SSI. Splenocytes recovered 3...
<p>Balb/c mice received BCG±CT <i>i.n.</i> followed by 1×10<sup>6</sup> CFU MVA85A 10 weeks later. L...
<p>Thirty days after vaccination, lung and spleen suspensions were stimulated <i>ex</i><i>vivo</i> w...
<p><b>A</b>, Immunization schedule to evaluate the immunogenicity of the SIVgag-LC3b fusion antigen....